Transcend Therapeutics acquired by Otsuka Pharmaceutical

Lilly reports initial clinical data for type II JAK2 inhibitor in patients with previously treated myelofibrosis

Menarini reports Phase 3 data for selinexor plus ruxolitinib in myelofibrosis

Simcere Pharmaceutical and Stanford Medicine agree research collaboration in idiopathic pulmonary fibrosis

ABL Diagnostics secures clinical research contract worth up to EUR2.7m through 2031

WeNatal introduces Iron+ iron and vitamin C supplement

FDA grants priority review for Genentech's Tecentriq in stage III dMMR/MSI-H colon cancer

XtalPi partners with leading biopharma to develop oral small molecule therapeutics for GPCR target

GlycoNex reports positive Phase III trial results for Denosumab biosimilar SPD8

Orionis Biosciences and Novartis form collaboration to advance molecular glue drug discovery

Sanofi halts phase 3 MOBILIZE study of riliprubart in CIDP

GMJ Technologies names new CEO

Lynk Pharmaceuticals' partner Formation Bio doses first participant in BLKR201 Phase 1 trial

Antengene granted IND approval in China for ATG-201 in autoimmune disease

FDA grants rare paediatric disease designation to RedHill's opaganib